The tumor microenvironment (TME) of MSI CRC tumors includes a higher number of tumor-infiltrating lymphocytes (TILs), including T helper 1 (Th1) CD4+ and cytotoxic CD8+ T cells, as well as antigen-presenting cells (APCs). Here, CD4 is linked to neoplasm.